Schalken JA - Search Results

1

Risk factors, genetic predisposition and mutations in the VHL gene in sporadic renal cell carcinoma: The Netherlands Cohort Study.

Van Dijk BA, Schouten LJ, Hulsbergen-van de Kaa CA, van Houwelingen KP, Schalken JA, Kiemeney LA, Geurts van Kessel AH, Bausch-Goldbohm RA, van den Brandt PA. Van Dijk BA, et al. Among authors: schalken ja. IARC Sci Publ. 2002;156:509-10. IARC Sci Publ. 2002. PMID: 12484247 No abstract available.

2

Demonstration of intermediate cells during human prostate epithelial differentiation in situ and in vitro using triple-staining confocal scanning microscopy.

van Leenders G, Dijkman H, Hulsbergen-van de Kaa C, Ruiter D, Schalken J. van Leenders G, et al. Lab Invest. 2000 Aug;80(8):1251-8. doi: 10.1038/labinvest.3780133. Lab Invest. 2000. PMID: 10950116 Free article.

3

Lower incidence of urothelial cell carcinoma due to the concept of a clonal origin.

Aben KK, Witjes JA, van Dijck JA, Schalken JA, Verbeek AL, Kiemeney LA. Aben KK, et al. Among authors: schalken ja. Eur J Cancer. 2000 Dec;36(18):2385-9. doi: 10.1016/s0959-8049(00)00324-5. Eur J Cancer. 2000. PMID: 11094314

4

Superficial and metachronous invasive bladder carcinomas are clonally related.

Vriesema JL, Aben KK, Witjes JA, Kiemeney LA, Schalken JA. Vriesema JL, et al. Among authors: schalken ja. Int J Cancer. 2001 Sep 1;93(5):699-702. doi: 10.1002/ijc.1402. Int J Cancer. 2001. PMID: 11477581

5

Diagnostic efficacy of the ImmunoCyt test to detect superficial bladder cancer recurrence.

Vriesema JL, Atsma F, Kiemeney LA, Peelen WP, Witjes JA, Schalken JA. Vriesema JL, et al. Among authors: schalken ja. Urology. 2001 Sep;58(3):367-71. doi: 10.1016/s0090-4295(01)01217-1. Urology. 2001. PMID: 11549482 Clinical Trial.

6

Expression of basal cell keratins in human prostate cancer metastases and cell lines.

van Leenders GJ, Aalders TW, Hulsbergen-van de Kaa CA, Ruiter DJ, Schalken JA. van Leenders GJ, et al. Among authors: schalken ja. J Pathol. 2001 Dec;195(5):563-70. doi: 10.1002/path.993. J Pathol. 2001. PMID: 11745692

7

Alcohol dehydrogenase type 3 (ADH3) and the risk of bladder cancer.

van Dijk B, van Houwelingen KP, Witjes JA, Schalken JA, Kiemeney LA. van Dijk B, et al. Among authors: schalken ja. Eur Urol. 2001 Nov;40(5):509-14. doi: 10.1159/000049827. Eur Urol. 2001. PMID: 11752857

8

Is increased CAG repeat length in the androgen receptor gene a risk factor for male subfertility?

Van Golde R, Van Houwelingen K, Kiemeney L, Kremer J, Tuerlings J, Schalken J, Meuleman E. Van Golde R, et al. J Urol. 2002 Feb;167(2 Pt 1):621-3. doi: 10.1016/S0022-5347(01)69098-0. J Urol. 2002. PMID: 11792931

9

Intermediate cells in normal and malignant prostate epithelium express c-MET: implications for prostate cancer invasion.

van Leenders G, van Balken B, Aalders T, Hulsbergen-van de Kaa C, Ruiter D, Schalken J. van Leenders G, et al. Prostate. 2002 May 1;51(2):98-107. doi: 10.1002/pros.10073. Prostate. 2002. PMID: 11948964

10

Single-nucleotide polymorphism in the E-cadherin gene promoter modifies the risk of prostate cancer.

Verhage BA, van Houwelingen K, Ruijter TE, Kiemeney LA, Schalken JA. Verhage BA, et al. Among authors: schalken ja. Int J Cancer. 2002 Aug 20;100(6):683-5. doi: 10.1002/ijc.10541. Int J Cancer. 2002. PMID: 12209606

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

423 results

Search Page

Filters